Knud Landmark

Summary

Affiliation: University of Oslo
Country: Norway

Publications

  1. ncbi request reprint [Omega-3-fatty acids still beneficial in cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, 0316 Oslo
    Tidsskr Nor Laegeforen 127:202-3. 2007
  2. ncbi request reprint [Can fish oils protect against development of atrial fibrillation?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 126:1621. 2006
  3. ncbi request reprint [Could intake of vitamins C and E inhibit development of Alzheimer dementia?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 126:159-61. 2006
  4. ncbi request reprint [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 128:294-7. 2008
  5. ncbi request reprint [Diuretics, hypertension and coronary heart disease]
    Knud Landmark
    Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:325-6. 2005
  6. ncbi request reprint [Do vitamins C and E protect against the development of carotid stenosis and cardiovascular disease?]
    Knud Landmark
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:159-62. 2005
  7. ncbi request reprint [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?]
    Knud Landmark
    Institutt for farmakoterapi, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:38-40. 2005
  8. ncbi request reprint [Mercury, fish, fish oil and the risk of cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:198-200. 2004
  9. ncbi request reprint [Magnesium in pre-eclampsia/eclampsia]
    Knud Landmark
    Institutt for farmakoterapi Postboks 1065 Blindern 0316 Oslo
    Tidsskr Nor Laegeforen 123:1084-5. 2003
  10. ncbi request reprint Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality
    Knud Landmark
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    Blood Press 12:40-5. 2003

Detail Information

Publications26

  1. ncbi request reprint [Omega-3-fatty acids still beneficial in cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, 0316 Oslo
    Tidsskr Nor Laegeforen 127:202-3. 2007
  2. ncbi request reprint [Can fish oils protect against development of atrial fibrillation?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 126:1621. 2006
  3. ncbi request reprint [Could intake of vitamins C and E inhibit development of Alzheimer dementia?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 126:159-61. 2006
    ..Oxidative stress is a possible pathogenetic factor and the anti-oxidating vitamins C and E could therefore have a beneficial effect and reduce the damage caused by beta-amyloid...
  4. ncbi request reprint [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 128:294-7. 2008
    ..The benefit of these drugs in clinical practice has not been satisfactorily documented...
  5. ncbi request reprint [Diuretics, hypertension and coronary heart disease]
    Knud Landmark
    Det medisinske fakultet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:325-6. 2005
  6. ncbi request reprint [Do vitamins C and E protect against the development of carotid stenosis and cardiovascular disease?]
    Knud Landmark
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:159-62. 2005
    ..It is, however, not clarified whether these vitamins may have a preventive effect against cardiovascular events...
  7. ncbi request reprint [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?]
    Knud Landmark
    Institutt for farmakoterapi, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 125:38-40. 2005
    ..There is no reason to change the current practice of choosing ACE inhibitors as first line treatment for these conditions. If ACE inhibitors cannot be used, ATII receptor blockers represent an acceptable alternative...
  8. ncbi request reprint [Mercury, fish, fish oil and the risk of cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:198-200. 2004
    ..One possible explanation for this paradox could be a high content of mercury in fish...
  9. ncbi request reprint [Magnesium in pre-eclampsia/eclampsia]
    Knud Landmark
    Institutt for farmakoterapi Postboks 1065 Blindern 0316 Oslo
    Tidsskr Nor Laegeforen 123:1084-5. 2003
  10. ncbi request reprint Antihypertensive therapy at the onset of an acute myocardial infarction predicts in-hospital mortality
    Knud Landmark
    Department of Pharmacotherapeutics, University of Oslo, Oslo, Norway
    Blood Press 12:40-5. 2003
    ....
  11. ncbi request reprint [Nitrate therapy during and after acute myocardial infarction]
    Knud Landmark
    Institutt for farmakoterapi, Universitetet i Oslo
    Tidsskr Nor Laegeforen 123:3377-80. 2003
    ..Nitrates have been an integral part of the therapy of ischaemic heart disease for more than 130 years. <..
  12. doi request reprint [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events]
    Knud Landmark
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo, Norway
    Tidsskr Nor Laegeforen 129:1740-4. 2009
    ..Such an increase could enhance the risk of cardiovascular events and have an unfavourable effect on prognosis, but available documentation is not conclusive...
  13. ncbi request reprint Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention
    Elena Kvan
    Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Norway
    Pharmacoepidemiol Drug Saf 15:261-7. 2006
    ..The aim of the study was to assess the use of cardiovascular drugs after an acute myocardial infarction (MI), with particular focus on statins, in very old patients as compared to younger patients...
  14. doi request reprint [Calcium antagonists in treatment of hypertension]
    Knud Landmark
    Institutt for farmakoterapi, Fakultetsdivisjonen Rikshospitalet, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo, Norway
    Tidsskr Nor Laegeforen 129:2488-9. 2009
    ..Which place do calcium antagonists have in the present treatment of hypertension?..
  15. ncbi request reprint Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function
    Aasmund Reikvam
    Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, Norway
    Scand Cardiovasc J 37:130-4. 2003
    ....
  16. ncbi request reprint [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?]
    Asmund Reikvam
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 123:1838-40. 2003
    ..Results from studies examining this issue have been published in recent years. We have evaluated the study results together with other factors that are decisive for implementation of the findings in clinical practice...
  17. ncbi request reprint [Alpha-linolenic acid, cardiovascular disease and sudden death]
    Knud Landmark
    Institutt for farmakoterapi, Det medisinske fakultet, Universitetet i Oslo, Boks 1065 Blindern, 0316 Oslo uio no
    Tidsskr Nor Laegeforen 126:2792-4. 2006
    ..This may explain the protective effect of ALA against cardiovascular diseases and sudden death...
  18. doi request reprint Choice of initial antihypertensive drugs and persistence of drug use--a 4-year follow-up of 78,453 incident users
    Randi Selmer
    Department of Pharmacoepidemiology, Norwegian Institute of Public Health, PO Box 4404, 0403, Nydalen, Oslo, Norway
    Eur J Clin Pharmacol 68:1435-42. 2012
    ....
  19. ncbi request reprint [Can hydrochlorothiazide and chlorthalidone be compared in the treatment of hypertension?]
    Ingrid Os
    Institutt for farmakoterapi, Universitetet i Oslo, Postboks 1065 Blindern, 0316 Oslo
    Tidsskr Nor Laegeforen 124:829. 2004
  20. doi request reprint [Fish and omega-3 fatty acids and heart failure]
    Knud Landmark
    Institutt for klinisk medisin Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo, Norway
    Tidsskr Nor Laegeforen 132:2281-4. 2012
    ..The article gives an overview of studies of the effects of fish and omega-3 fatty acids on the risk of heart failure and on mortality in heart failure patients...
  21. ncbi request reprint [Rivastigmine against dementia in Parkinson disease?]
    Knud Landmark
    Tidsskr Nor Laegeforen 127:2973; author reply 2973-4. 2007
  22. ncbi request reprint [Wrong about thiazides]
    Knud Landmark
    Tidsskr Nor Laegeforen 125:1045-6; author reply 1046. 2005
  23. ncbi request reprint [Misleading information about thiazides]
    Knud Landmark
    Tidsskr Nor Laegeforen 125:328; author reply 328. 2005
  24. ncbi request reprint [Thiazides (only) and hard endpoints]
    Knud Landmark
    Tidsskr Nor Laegeforen 124:2942; author reply 2942-3. 2004
  25. ncbi request reprint [Hypokalemia can accelerate the development of cerebrovascular and cardiovascular disease]
    Knud Landmark
    Institutt for farmakoterapi Postboks 1065 Blindern 0316 Oslo
    Tidsskr Nor Laegeforen 122:499-501. 2002
    ..Hypokalaemia is known to precipitate cardiac arrhythmias. Hypokalaemia can also give rise to adverse cardiovascular effects not related to arrhythmias...
  26. ncbi request reprint [Anticholesteremic agents and omega-3 fatty acids]
    Knud Landmark
    Tidsskr Nor Laegeforen 123:212; author reply 212. 2003